In addition to improving pancreatic insulin secretion, experimental models show that osteocalcin can protect against high-fat-induced obesity, insulin resistance, and nonalcoholic fatty liver disease (NAFLD) [57, 58]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.